期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MOLECULAR CARCINOGENESIS LetPub Score 7.5
50 ratings
Rate
Reputation 8.7 Influence 6.3 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | MOL CARCINOGEN | ||||||||||||||||||||
ISSN | 0899-1987 | ||||||||||||||||||||
E-ISSN | 1098-2744 | ||||||||||||||||||||
h-index | 88 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 3.30%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2744 | ||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/mc-wiley | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Wiley-Liss Inc. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1988 | ||||||||||||||||||||
每年文章數 | 151每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 13.47% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0899-1987%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[MOLECULAR CARCINOGENESIS] 的評論 | 撰寫評論 |
作者: Augus Fowler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-14 13:38:51 評論於 Research focus: Tumor experience sharing: It has been over a month since submission, and it has been under review since the second day without any changes. I am not sure if it has been sent for external review, feeling anxious but hesitant to urge(0) 讚! | Augus Fowler |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-29 12:31:59 評論於 I'm about to collapse, I can't wait any longer(0) 讚! | 岱宗雨旋 |
作者: 韦陀耀坤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-21 20:00:02 評論於 Still no news(0) 讚! | 韦陀耀坤 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-17 22:59:36 評論於 How are you? Any updates? Mine is similar to yours, still waiting for the revisions and external review(0) 讚! | 岱宗雨旋 |
作者: 蒙德高昂 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-17 22:36:55 評論於 Do you need the original data for this magazine, experts?(0) 讚! | 蒙德高昂 |
作者: Augus Fowler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 18:22:39 評論於 Hello, may I ask if this magazine under Review (with a capital R) is being edited or has been sent out for external review? It has been a week already(0) 讚! | Augus Fowler |
作者: Augus Fowler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 12:58:33 評論於 Hello, may I ask if this magazine under Review (capital R) is being edited or has been sent for external review? It has been one week already(0) 讚! | Augus Fowler |
作者: 平原从安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-06 09:49:36 評論於 Review speed: 6.0 Research focus: Tumor Experience sharing: Submitted on December 23, 2023, revised on February 5, 2024, with four issues. Revised on March 18, 2024, and still no news until now(0) 讚! | 平原从安 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-29 15:30:43 評論於 How was it finally resolved, may I ask?(0) 讚! | 岱宗雨旋 |
作者: 韦陀耀坤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-24 11:08:21 評論於 Research focus: Tumors; Non-coding RNA; Molecular Mechanisms Sharing of Experience: I have revised the manuscript three times, and after the third revision, it was sent out for external review for one month. The key point in the third review was just two descriptive issues, I don't know what they are nitpicking about(0) 讚! | 韦陀耀坤 |
作者: 墟散云泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-12 23:37:14 評論於 There is something about you that makes my heart race(0) 讚! | 墟散云泽 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-20 17:18:33 評論於 Major revision was given 60 days. Two reviewers did not require additional experiments, mostly clarifications on wording and some supplementary data methods, which have all been addressed. The revised version was submitted on 2.21 and is currently under review since 2.23. Is there still hope for this submission???(0) 讚! | 岱宗雨旋 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-20 14:06:04 評論於 How is the progress of your revision going??? Our major revision is given 60 days. Two reviewers did not require additional experiments, mainly focusing on clarifying some statements and adding details to the data analysis methods. All revisions have been explained and made, resubmitted on 2.21, and under review again on 2.23. As of now, there is still no news. Is there still hope for this???(0) 讚! | 岱宗雨旋 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-20 11:34:35 評論於 Major revision, given 60 days. Two reviewers, no need for additional experiments, mainly issues with presentation and some clarification on data analysis methods, all addressed. Revised on 2.21, under review again on 2.23, still no news as of now. Is there still hope???(0) 讚! | 岱宗雨旋 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-20 10:58:47 評論於 Major revision was given 60 days. Two reviewers did not request additional experiments, mostly addressing minor issues in wording and adding clarity to some data methods. All revisions were completed on 2.21, and the manuscript has been under review again since 2.23, now for over a month. Is there still hope for acceptance???(0) 讚! | 岱宗雨旋 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-20 09:03:43 評論於 Major revision, given 60 days. Two reviewers, did not require additional experiments, mostly clarification of statements and supplementing data methods. Revised on 2/21, under review again on 2/23, still no news. Is there still hope???(0) 讚! | 岱宗雨旋 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-20 08:46:37 評論於 Major revision, given 60 days. Two reviewers, no need for additional experiments, mostly just clarifications on wording and some supplementary data and methods, all addressed. Revised on 2.21, then back under review on 2.23, and still no updates until now. Is there still hope???(0) 讚! | 岱宗雨旋 |
作者: 墟散云泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-17 20:29:48 評論於 Does OA or non-OA affect online time? I chose non-OA(0) 讚! | 墟散云泽 |
作者: 一条小秋华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-16 21:40:29 評論於 Just wait for them to notify, you can choose between OA and non-OA(0) 讚! | 一条小秋华 |
作者: 一条小秋华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-16 17:21:38 評論於 Just waiting for the proof, it will be online very soon(0) 讚! | 一条小秋华 |
作者: 墟散云泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 23:13:39 評論於 After receiving it, should we wait for him to send another email to fill in some materials? The issue of layout fee was not mentioned, so I'm a bit confused, not sure what to do next(0) 讚! | 墟散云泽 |
作者: 墟散云泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 22:49:44 評論於 After receiving it, do I wait for him to send another email to fill in some materials? There was no mention of the layout fee, I am a bit confused, not sure what to do next(0) 讚! | 墟散云泽 |
作者: 墟散云泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 20:32:10 評論於 Do I need to provide all authors' consent forms after receiving the acceptance? And wait for the proof notification?(0) 讚! | 墟散云泽 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 23:44:29 評論於 Reviewer for one month and then evaluating the recommendation, is there any hope for this situation?(0) 讚! | 岱宗雨旋 |
作者: 岱宗雨旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 23:25:45 評論於 Review under one month and then evaluating recommendation, is there hope for this situation?(0) 讚! | 岱宗雨旋 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us